197 related articles for article (PubMed ID: 29945931)
1. Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation.
Sim-Selley LJ; Wilkerson JL; Burston JJ; Hauser KF; McLane V; Welch SP; Lichtman AH; Selley DE
J Pharmacol Exp Ther; 2018 Sep; 366(3):509-518. PubMed ID: 29945931
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
Li C; Li JN; Kays J; Guerrero M; Nicol GD
J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
[TBL] [Abstract][Full Text] [Related]
3. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
[TBL] [Abstract][Full Text] [Related]
4. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
[TBL] [Abstract][Full Text] [Related]
5. Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.
Grenald SA; Doyle TM; Zhang H; Slosky LM; Chen Z; Largent-Milnes TM; Spiegel S; Vanderah TW; Salvemini D
Pain; 2017 Sep; 158(9):1733-1742. PubMed ID: 28570482
[TBL] [Abstract][Full Text] [Related]
6. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
Janes K; Little JW; Li C; Bryant L; Chen C; Chen Z; Kamocki K; Doyle T; Snider A; Esposito E; Cuzzocrea S; Bieberich E; Obeid L; Petrache I; Nicol G; Neumann WL; Salvemini D
J Biol Chem; 2014 Jul; 289(30):21082-97. PubMed ID: 24876379
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors.
Zhang DD; Linke B; Suo J; Zivkovic A; Schreiber Y; Ferreirós N; Henke M; Geisslinger G; Stark H; Scholich K
Biol Chem; 2015 Jun; 396(6-7):783-94. PubMed ID: 25720064
[TBL] [Abstract][Full Text] [Related]
8. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.
Cantalupo A; Gargiulo A; Dautaj E; Liu C; Zhang Y; Hla T; Di Lorenzo A
Hypertension; 2017 Aug; 70(2):426-434. PubMed ID: 28607130
[TBL] [Abstract][Full Text] [Related]
9. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.
Tsai HC; Huang Y; Garris CS; Moreno MA; Griffin CW; Han MH
JCI Insight; 2016 Jun; 1(9):e86462. PubMed ID: 27699272
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
Singh SK; Spiegel S
Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.
Stockstill K; Doyle TM; Yan X; Chen Z; Janes K; Little JW; Braden K; Lauro F; Giancotti LA; Harada CM; Yadav R; Xiao WH; Lionberger JM; Neumann WL; Bennett GJ; Weng HR; Spiegel S; Salvemini D
J Exp Med; 2018 May; 215(5):1301-1313. PubMed ID: 29703731
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate receptor modulation attenuate mechanical allodynia in mouse model of chronic complex regional pain syndrome by suppressing pathogenic astrocyte activation.
Lee BJ; Kim JY; Cho HJ; Park D
Reg Anesth Pain Med; 2020 Mar; 45(3):230-238. PubMed ID: 31969447
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.
Chen Z; Doyle TM; Luongo L; Largent-Milnes TM; Giancotti LA; Kolar G; Squillace S; Boccella S; Walker JK; Pendleton A; Spiegel S; Neumann WL; Vanderah TW; Salvemini D
Proc Natl Acad Sci U S A; 2019 May; 116(21):10557-10562. PubMed ID: 31068460
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.
Zhao P; Yang X; Yang L; Li M; Wood K; Liu Q; Zhu X
FASEB J; 2017 Jan; 31(1):172-179. PubMed ID: 27671228
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents.
Doyle TM; Hutchinson MR; Braden K; Janes K; Staikopoulos V; Chen Z; Neumann WL; Spiegel S; Salvemini D
J Neuroinflammation; 2020 Oct; 17(1):314. PubMed ID: 33092620
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment.
Squillace S; Niehoff ML; Doyle TM; Green M; Esposito E; Cuzzocrea S; Arnatt CK; Spiegel S; Farr SA; Salvemini D
J Clin Invest; 2022 Sep; 132(17):. PubMed ID: 36047496
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive activity of the S1P-receptor agonist FTY720.
Coste O; Pierre S; Marian C; Brenneis C; Angioni C; Schmidt H; Popp L; Geisslinger G; Scholich K
J Cell Mol Med; 2008 Jun; 12(3):995-1004. PubMed ID: 18494940
[TBL] [Abstract][Full Text] [Related]
18. FTY720 Phosphate Activates Sphingosine-1-Phosphate Receptor 2 and Selectively Couples to Gα12/13/Rho/ROCK to Induce Myofibroblast Contraction.
Sobel K; Monnier L; Menyhart K; Bolinger M; Studer R; Nayler O; Gatfield J
Mol Pharmacol; 2015 Jun; 87(6):916-27. PubMed ID: 25762025
[TBL] [Abstract][Full Text] [Related]
19. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
Tzschentke TM; Linz K; Frosch S; Christoph T
Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
[TBL] [Abstract][Full Text] [Related]
20. Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents.
Doyle TM; Janes K; Chen Z; Grace PM; Esposito E; Cuzzocrea S; Largent-Milnes TM; Neumann WL; Watkins LR; Spiegel S; Vanderah TW; Salvemini D
Pain; 2020 Sep; 161(9):2107-2118. PubMed ID: 32301840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
